EFFECT OF MACROLIDE ON LUNG FUNCTION AND COMPUTED TOMOGRAPHY (CT) SCORE IN NON-CYSTIC FIBROSIS BRONCHIECTASIS

REFERENCES

• Goeminne P, Dupont L. Non-cystic fibrosis bronchiectasis: diagnosis and man-agement in 21st century. Postgrad Med J 2070 Aug; 86: 493–501.
   Web of Science ®Google Scholar
• Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, Roman-Sanchez P. Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007 Nov; 132: 1565–1572.
   PubMed Web of Science ®Google Scholar
• Wolter J, Seeney S, Bell S, Bowler S, Masel P. McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a ran-domised trial. Thorax 2002 Mar; 57:212–216.
   PubMed Web of Science ®Google Scholar
• Anwar GA, Bourke SC, Afolabi G, Middleton P, Ward C, Rutherford RM. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med 2008 Oct; 102:1494–1496.
   PubMed Web of Science ®Google Scholar
• Cymbala AA, Edmonds LC, Bauer MA, Jederlinic PJ, May JJ, Victory JM, et al. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treat Respir Med 2005; 4: 117–122.
   PubMedGoogle Scholar
• Tsang KW, Ho PI, Chan KN, Lp MS, Lam WK, Ho CS, et al. A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J 1999 Feb; 13: 361–364.
   PubMed Web of Science ®Google Scholar
• Davies G, Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithromycin. Thorax 2004 Jun; 59: 540–541.
   PubMed Web of Science ®Google Scholar
• Tamaoki J, Takeyama K, Tagaya E, Konno K. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother 1995 Aug; 39: 1688–1690.
   PubMed Web of Science ®Google Scholar
• Tagaya E, Tamaoki J, Kondo M, Nagai A. Effect of a short course of clarithromy-cin therapy on sputum production in patients with chronic airway hypersecre-tion. Chest 2002 Jul; 122: 213–218.
   PubMed Web of Science ®Google Scholar
• Koh YY, Lee MH, Sun YH, Sung KW, Chae JH. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-con-trolled study. Eur Respir J 1997 May; 10: 994–999.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Fujishima S, Inoue T, Ohkubo Y, Soejima K, Waki Y, et al. Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection. Eur Respir J 1999 Jun; 13:1371–1379.
   PubMed Web of Science ®Google Scholar
• Dogru D, Dalgic F, Kiper N, Ozcelik U, Yalcin E, Asian AT, et al. Long-term clarithromycin in cystic fibrosis: effects on inflammatory markers in BAL and clinical status. Turk J Pediatr 2009 Sep; 51:416–423.
   PubMed Web of Science ®Google Scholar
• Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, et al. Reproducibil-ity of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 2006 Mar; 21: 14–21.
   PubMed Web of Science ®Google Scholar
• Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution com-puted tomography in young patients with cystic fibrosis: distribution of abnormali-ties and correlation with pulmonary function tests. J Pediatr 2004 Jul; 145: 32–38.
   PubMed Web of Science ®Google Scholar
• Soens J, Goeminne PC, De Keyzer F., Dupont LJ, De Weyer W. CT evaluation of azithromycin therapy in non-cystic fibrosis bronchiectatic patients. scientific session, ESTI, Bern, Switzerland 2010 ss 04.6, 39. 2010. (abstract)
   Google Scholar
• Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bron-chiectasis. Thorax 2010 Jul; 65 Suppl 1: i1–58.
   PubMed Web of Science ®Google Scholar
• Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bron-chiectasis. Thorax 2010 Jul; 65: 577.
   PubMed Web of Science ®Google Scholar
• Cademartiri F, Luccichenti G, Palumbo AA, Maffei E, Pisi G, Zompatori M, et al. Predictive value of chest CT in patients with cystic fibrosis: a single-center 10-year experience. AJR Am J Roentgenol 2008 Jun; 190: 1475–1480.
   Web of Science ®Google Scholar
• de Jong PA, Lindblad A, Rubin L, Hop WC, de Jongste JC, Brink M, et al. Progres-sion of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006 Jan; 61:80–85.
   PubMed Web of Science ®Google Scholar
• Judge EP, Dodd JD, Masterson JB, Gallagher CG. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest 2006 Nov; 130: 1424–1432.
   PubMed Web of Science ®Google Scholar